Form 8-K REPLIGEN CORP For: Nov 06

Go back to Form 8-K REPLIGEN CORP For: Nov 06

Repligen (RGEN) Reports In-Line Q3 EPS

November 6, 2014 9:01 AM EST

Repligen (NASDAQ: RGEN) reported Q3 EPS of $0.04, in-line with the analyst estimate of $0.04. Revenue for the quarter came in at $15.3 million versus the consensus estimate of $15.6 million.

Repligen sees FY2014 revenue of $60-62 million, versus prior guidance of $59-62 million and the consensus of $0.28... More